JP Morgan Chase’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7 Hold
1
﹤0.01% 7663
2026
Q1
$8 Hold
1
﹤0.01% 7442
2025
Q4
$11 Buy
+1
New +$13 ﹤0.01% 7328
2025
Q3
Sell
-1
Closed -$7 7460
2025
Q2
$7 Hold
1
﹤0.01% 6993
2025
Q1
$7 Hold
1
﹤0.01% 7209
2024
Q4
$9 Hold
1
﹤0.01% 7318
2024
Q3
$12 Hold
1
﹤0.01% 7279
2024
Q2
$13 Hold
1
﹤0.01% 7194
2024
Q1
$17 Hold
1
﹤0.01% 7184
2023
Q4
$19 Hold
1
﹤0.01% 7358
2023
Q3
$36 Hold
1
﹤0.01% 7048
2023
Q2
$44 Hold
1
﹤0.01% 6751
2023
Q1
$0 Hold
1
﹤0.01% 6803
2022
Q4
$0 Hold
1
﹤0.01% 6628
2022
Q3
$0 Hold
1
﹤0.01% 6534
2022
Q2
$0 Sell
1
-316
-100% -$37.1K ﹤0.01% 6540
2022
Q1
$37K Buy
317
+57
+22% +$9.43K ﹤0.01% 5903
2021
Q4
$67K Hold
260
﹤0.01% 5840
2021
Q3
$71K Buy
260
+1
+0.4% +$289 ﹤0.01% 5722
2021
Q2
$111K Buy
+259
New +$98.6K ﹤0.01% 5505
2020
Q2
Sell
-20
Closed -$3K 5440
2020
Q1
$3K Buy
+20
New +$2.96K ﹤0.01% 5156
2018
Q3
Sell
-1
Closed -$1K 5697
2018
Q2
$1K Hold
1
﹤0.01% 5484
2018
Q1
$1K Hold
1
﹤0.01% 5312
2017
Q4
$1K Hold
1
﹤0.01% 5387
2017
Q3
$1K Hold
1
﹤0.01% 4904
2017
Q2
$1K Buy
+1
New +$1.04K ﹤0.01% 4875

Other funds holding DRIO

JP Morgan Chase's DRIO Position: Q2 2026 in Review

JP Morgan Chase held its DarioHealth (DRIO) position steady in Q2 2026 at 1 share worth $7. The position accounts for ﹤0.01% of the portfolio, ranked #7663.

JP Morgan Chase first reported a position in DRIO in Q2 2017 and has held it in 26 quarters since. The position peaked at $111K in Q2 2021. 21 funds tracked by Wall St. Rank hold DRIO as of Q2 2026.

  • JP Morgan Chase held 1 share of DarioHealth worth $7 as of Q2 2026.
  • JP Morgan Chase left its DarioHealth share count unchanged in Q2 2026.
  • DarioHealth made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #7663 holding.
  • JP Morgan Chase first reported a position in DarioHealth in Q2 2017 and has held it in 26 quarters since.
  • JP Morgan Chase's DarioHealth position peaked at $111K in Q2 2021.
  • 21 funds tracked by Wall St. Rank held DarioHealth as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.